Comparing the Sensitivities of Measures of Adherence to Antihypertensive Drugs Using Korean National Health Insurance Claims Data

References

• Brown MT, Bussell JK. Medication Adherence: WHO Cares? Elsevier; 2011:304–314.
   Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi:10.1377/hlthaff.2009.1087
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• Van Staa T-P, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol. 1994;47(2):183–189. doi:10.1016/0895-4356(94)90023-X
   PubMed Web of Science ®Google Scholar
• Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–116. doi:10.1016/S0895-4356(96)00268-5
   PubMed Web of Science ®Google Scholar
• Blais L, Vilain A, Kettani F-Z, et al. Accuracy of the days’ supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids. BMJ Open. 2014;4(11):11. doi:10.1136/bmjopen-2014-005903
   Web of Science ®Google Scholar
• Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090. doi:10.1016/S0149-2918(99)80026-5
   PubMed Web of Science ®Google Scholar
• Spilker B, Cramer J. Patient Compliance in Medical Practice and Clinical Trials. Raven Press; 1991.
   Google Scholar
• Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C. Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res. 2012;12(1):155. doi:10.1186/1472-6963-12-155
   PubMed Web of Science ®Google Scholar
• Pednekar PP, Agh T, Malmenäs M, et al. Methods for measuring multiple medication adherence: a systematic review–report of the ISPOR medication adherence and persistence special interest group. Value Health. 2019;22(2):139–156. doi:10.1016/j.jval.2018.08.006
   PubMed Web of Science ®Google Scholar
• Zongo A, Grégoire J-P, Moisan J, Guénette L. Measuring adherence to oral antidiabetic multi-drug treatment: comparative validity of prescription claims-based adherence measures against hospitalization. Res Social Adm Pharm. 2019;15(6):738–743. doi:10.1016/j.sapharm.2018.09.005
   PubMed Web of Science ®Google Scholar
• Pye SR, Sheppard T, Joseph RM, et al. Assumptions made when preparing drug exposure data for analysis have an impact on results: a n unreported step in pharmacoepidemiology studies. Pharmacoepidemiol Drug Saf. 2018;27(7):781–788. doi:10.1002/pds.4440
   Web of Science ®Google Scholar
• Bjarnadottir MV, Czerwinski D, Onukwugha E. Sensitivity of the medication possession ratio to modelling decisions in large claims databases. PharmacoEconomics. 2018;36(3):369–380. doi:10.1007/s40273-017-0597-y
   Web of Science ®Google Scholar
• Arnet I, Abraham I, Messerli M, Hersberger KE. A method for calculating adherence to polypharmacy from dispensing data records. Int J Clin Pharm. 2014;36(1):192–201. doi:10.1007/s11096-013-9891-8
   Web of Science ®Google Scholar
• Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–1288. doi:10.1345/aph.1H018
   PubMed Web of Science ®Google Scholar
• Jung M, Choo E, Lee S. Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea. Clin Epidemiol. 2020;12:963. doi:10.2147/CLEP.S265966
   Web of Science ®Google Scholar
• Geest SD, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30‐35. doi:10.7326/M18-0543
   Web of Science ®Google Scholar
• Nau DP. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. Springfield, VA: Pharmacy Quality Alliance; 2012.
   Google Scholar
• Lee J, Lee JS, Park S-H, Shin SA, Kim K. Cohort profile: the national health insurance service–national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46(2):e15–e15.
   PubMed Web of Science ®Google Scholar
• Vink N, Klungel O, Stolk R, Denig P. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf. 2009;18(2):159–165. doi:10.1002/pds.1698
   PubMed Web of Science ®Google Scholar
• Hedna K, Hakkarainen KM, Gyllensten H, et al. Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications? PLoS One. 2015;10(9):e0137451. doi:10.1371/journal.pone.0137451
   PubMed Web of Science ®Google Scholar
• Quisel T, Foschini L, Zbikowski SM, Juusola JL. The association between medication adherence for chronic conditions and digital health activity tracking: retrospective analysis. J Med Internet Res. 2019;21(3):e11486. doi:10.2196/11486
   PubMed Web of Science ®Google Scholar
• Arnet I, Greenland M, Knuiman MW, et al. Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database. Clin Epidemiol. 2018;10:1181. doi:10.2147/CLEP.S153496
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15(7):457.
   PubMed Web of Science ®Google Scholar
• Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Adherence: comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43(3):413–422. doi:10.1345/aph.1L496
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Patrick AR, Stürmer T, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45(10SUPL):S131. doi:10.1097/MLR.0b013e318070c08e
   Web of Science ®Google Scholar
• Baggarly SA, Kemp RJ, Wang X, Magoun AD. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Res Social Adm Pharm. 2014;10(6):e99–e112. doi:10.1016/j.sapharm.2014.02.002
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Elizabeth H, Joyce C, et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of medication adherence among older adults (CoSMO). J Hypertens. 2015;33(2):412. doi:10.1097/HJH.0000000000000382
   PubMed Web of Science ®Google Scholar
• Chapman RH, Liu LZ, Girase PG, Straka RJ. Determining initial and follow-up costs of cardiovascular events in a US managed care population. BMC Cardiovasc Disord. 2011;11(1):1–10. doi:10.1186/1471-2261-11-11
   Web of Science ®Google Scholar
• Jung M, Lee S. Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a Population-Based Cohort Study in Korea. Drugs Aging. 2020;37(1):43–55. doi:10.1007/s40266-019-00723-3
   Web of Science ®Google Scholar
• Jung M, Lee S. Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia. Pharmacotherapy. 2019;39(2):129–139. doi:10.1002/phar.2211
   Web of Science ®Google Scholar
• Alfian SD, Denig P, Coelho A, Hak E. Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the Netherlands. PLoS One. 2019;14(11):e0225390. doi:10.1371/journal.pone.0225390
   Web of Science ®Google Scholar
• Park E, Ryu DH, Kam S. Medication adherence trends and its related factors in newly diagnosed hypertensive patients. J Health Info Stat. 2019;44(2):141–151. doi:10.21032/jhis.2019.44.2.141
   Google Scholar
• Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 2012;5(2):79.
   PubMedGoogle Scholar
• Ihle P, Krueger K, Schubert I, et al. Comparison of different strategies to measure medication adherence via claims data in patients with chronic heart failure. Clin Pharmacol Ther. 2019;106(1):211–218. doi:10.1002/cpt.1378
   Web of Science ®Google Scholar
• Lee H-Y, Shin J, Kim G-H, et al. 2018 Korean society of hypertension guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25(1):1–24. doi:10.1186/s40885-019-0124-x
   Web of Science ®Google Scholar
• Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611–1621. doi:10.1161/CIRCULATIONAHA.110.983874
   PubMed Web of Science ®Google Scholar
• Erkens JA, Panneman MM, Klungel OH, Boom GVD, Prescott MF, Herings RM. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO Study. Pharmacoepidemiol Drug Saf. 2005;14(11):795–803. doi:10.1002/pds.1156
   Web of Science ®Google Scholar